IO Health, a Los Angeles-based AI-driven compliance and quality platform for home health and hospice providers, has raised $2 million in Seed funding.
Investors
The round was led by Nina Capital, with participation from healthcare industry veterans and strategic angel investors.
Founded in 2019, Nina Capital is a venture capital firm investing in health tech companies with global potential. With offices in Barcelona and Silicon Valley, the firm invests in healthcare transformation powered by information technology, including digital health, data science, AI/machine learning, computing, and next-generation data-driven medical devices.
Marc Subirats, General Partner at Nina Capital, will join io Health’s Board of Directors.
IO Health Use of Funds
The company will use the funds to scale its Care Optimized suite and expand its AI-driven platform across home health and hospice markets.
About IO Health
Led by CEO Dr. David Bell, IO Health is an AI-powered technology company serving the home health and hospice sector. The company’s solutions are designed to enhance efficiency, improve patient care, and strengthen financial performance. IO Health’s Care Optimized™ suite includes ioAssist for point-of-care validation, compliance, and best practice education; ioIQ for QA optimization; and ioDoc for automated patient handbooks. Headquartered in Los Angeles, California, IO Health’s patent-pending technology delivers real-time productivity to clinicians at the point of care.
Funding Details
Company: IO Health Technologies, LLC
Raised: $2.0M
Round: Seed
Funding Date: October 2025
Lead Investor: Nina Capital
Additional Investors:
Company Website: https://iohealth.ai/
Software Category: Healthtech / AI-driven compliance & quality platform
Source: https://iohealth.ai/io-health-seed-funding/